DCGI allows Biophore India to manufacture coronavirus drug Favipiravir API
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read more
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreBhubaneswar: The Odisha government received Monday the first consignment of ‘Remdesivir’ and ‘Favipiravir’ medicines for treatment of COVID-19 patients. Additional ...
Read moreNew Delhi: Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the ...
Read moreNew Delhi: Glenmark Pharmaceuticals announced Tuesday that it will commence another new Phase 3 clinical trial. This will be on ...
Read moreBangalore: Glenmark Pharmaceuticals Ltd said Thursday it will start clinical trials in India of antiviral drug ‘favipiravir’. It is being ...
Read more
The shadow of Donald Trump, with trade and economic uncertainties linked to his return to the White House in January...
Read more
I n what appears to be a pro-incumbency mandate, the Mahayuti coalition led by the BJP swept the Maharashtra Assembly...
Read more
“India and Bangladesh share deep-rooted bonds of history, language, culture, and a multitude of other commonalities. The outstanding nature of...
Read more
Since its second term, the Modi government has retained top civil servants beyond retirement for ‘continuity in policymaking’. Weeks after...
Read more
